Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Transglutaminase regulation of cell function
RL Eckert, MT Kaartinen, M Nurminskaya… - Physiological …, 2014 - journals.physiology.org
Transglutaminases (TGs) are multifunctional proteins having enzymatic and scaffolding
functions that participate in regulation of cell fate in a wide range of cellular systems and are …
functions that participate in regulation of cell fate in a wide range of cellular systems and are …
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology
SA Kozek-Langenecker, A Afshari… - European Journal of …, 2013 - journals.lww.com
The aims of severe perioperative bleeding management are three-fold. First, preoperative
identification by anamesis and laboratory testing of those patients for whom the …
identification by anamesis and laboratory testing of those patients for whom the …
Foxp3+ CD4+ T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte/Macrophage Differentiation
J Weirather, UDW Hofmann, N Beyersdorf… - Circulation …, 2014 - ahajournals.org
Rationale: An exaggerated or persistent inflammatory activation after myocardial infarction
(MI) leads to maladaptive healing and subsequent remodeling of the left ventricle. Foxp3+ …
(MI) leads to maladaptive healing and subsequent remodeling of the left ventricle. Foxp3+ …
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
A current paradigm states that monocytes circulate freely and patrol blood vessels but
differentiate irreversibly into dendritic cells (DCs) or macrophages upon tissue entry. Here …
differentiate irreversibly into dendritic cells (DCs) or macrophages upon tissue entry. Here …
Factor XIII: a coagulation factor with multiple plasmatic and cellular functions
Factor XIII (FXIII) is unique among clotting factors for a number of reasons: 1) it is a
protransglutaminase, which becomes activated in the last stage of coagulation; 2) it works …
protransglutaminase, which becomes activated in the last stage of coagulation; 2) it works …
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
T Kempf, A Zarbock, C Widera, S Butz, A Stadtmann… - Nature medicine, 2011 - nature.com
Inflammatory cell recruitment after myocardial infarction needs to be tightly controlled to
permit infarct healing while avoiding fatal complications such as cardiac rupture. Growth …
permit infarct healing while avoiding fatal complications such as cardiac rupture. Growth …
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice
MD Majmudar, EJ Keliher, T Heidt, F Leuschner… - Circulation, 2013 - ahajournals.org
Background—Exaggerated and prolonged inflammation after myocardial infarction (MI)
accelerates left ventricular remodeling. Inflammatory pathways may present a therapeutic …
accelerates left ventricular remodeling. Inflammatory pathways may present a therapeutic …
Periostin is essential for cardiac healingafter acute myocardial infarction
M Shimazaki, K Nakamura, I Kii, T Kashima… - The Journal of …, 2008 - rupress.org
Acute myocardial infarction (AMI) is a common and lethal heart disease, and the recruitment
of fibroblastic cells to the infarct region is essential for the cardiac healing process. Although …
of fibroblastic cells to the infarct region is essential for the cardiac healing process. Although …
Impaired Infarct Healing in Atherosclerotic Mice With Ly-6ChiMonocytosis
Objectives: The aim of this study was to test whether blood monocytosis in mice with
atherosclerosis affects infarct healing. Background: Monocytes are cellular protagonists of …
atherosclerosis affects infarct healing. Background: Monocytes are cellular protagonists of …
Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders
SE Iismaa, BM Mearns, L Lorand… - Physiological …, 2009 - journals.physiology.org
The human transglutaminase (TG) family consists of a structural protein, protein 4.2, that
lacks catalytic activity, and eight zymogens/enzymes, designated factor XIII-A (FXIII-A) and …
lacks catalytic activity, and eight zymogens/enzymes, designated factor XIII-A (FXIII-A) and …